Dr. Suroosh S. Marzban, MD

Dr. Marzban practices at Trustees of Columbia University in the City of New York in Bronx, New York.

Dr. Marzban's NPI, 1265812812, was assigned on June 8, 2015. Dr. Marzban graduated from USF Health Morsani College of Medicine in 2015. Dr. Marzban's New York license number on file is 305600.

Dr. Marzban's primary practice is Trustees of Columbia University in the City of New York, at 3219 E Tremont Ave, Bronx, NY 10461 in Bronx County. The practice phone is (646) 317-7111.

Dr. Marzban's primary practice is Trustees of Columbia University in the City of New York in Bronx, New York. Dr. Marzban is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Marzban to 1 more hospital, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marzban practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Marzban's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Marzban is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Marzban's licenses on file in 2 states: New York and Illinois.

Dmand AI lists amputation, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, circulatory problems in extremities, deep vein thrombosis (DVT), leg revascularization and lymphedema among the conditions Dr. Marzban treats.

CMS data shows 1,032 Medicare services from Dr. Marzban across 15 procedure codes in 2024, for 282 Medicare patients. Medicare paid $121,146 for them. Every service was in an office.

CMS counts 282 Medicare patients who saw Dr. Marzban in 2024. The largest group is 75 to 84, with 102 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Marzban's median patient age at 67, with 57% women.

In 2024, Dr. Marzban wrote 345 Medicare Part D claims for 131 patients. 84% of them were for generic drugs. CMS names the drug for 231 of them, across 11 drugs with 11 or more claims each, at $25,928 in total drug cost. In 2023, CMS named 77 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Marzban for performance year 2024, reported through an alternative payment model (APM). Dr. Marzban accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Marzban as offering telehealth. CMS counts 197 procedures of removal of tissue by Dr. Marzban, more than 91% of the clinicians it reports for that procedure.

Dmand AI links 16 papers to Dr. Marzban, published from 2012 to 2024. 2012 was the busiest year, with 4. The most frequent topics are Melanoma, Skin Neoplasms and Lymphatic Metastasis. Dr. Marzban has published most often in Ann Surg Oncol. Dr. Marzban's most frequent co-authors are Vernon K. Sondak, MD, Jonathan S. Zager, MD and Jane L. Messina, MD.

CMS Open Payments shows 97 general payments to Dr. Marzban from 22 drug and device companies from 2017 to 2025. Device or supply loans make up the largest share, 62% of the total. AngioDynamics, Inc. paid the most, $14,341.

Dr. Marzban graduated from USF Health Morsani College of Medicine in 2015.

Dr. Marzban is in network with 16 carriers, including Elevance, Aetna and MVP Health Care. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.